DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Propranolol hydrochlorideis the generic ingredient in six branded drugs marketed by Ani Pharms Inc, Actavis Elizabeth, Adare Pharms Inc, Amta, Inwood Labs, Mylan, Nortec Dev Assoc, Upsher Smith Labs, Zydus Pharms Usa Inc, Roxane, Athenex Inc, Baxter Hlthcare Corp, Fosun Pharma, Fresenius Kabi Usa, Hikma Farmaceutica, Smith And Nephew, Solopak, Pierre Fabre Derma, Hikma, Morton Grove, Wyeth Ayerst, Wyeth Pharms, Dava Pharms Inc, Duramed Pharms Barr, Impax Labs Inc, Innogenix, Interpharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Lederle, Northstar Hlthcare, Par Pharm, Purepac Pharm, Sandoz, Schering, Superpharm, Teva, Vintage Pharms, Warner Chilcott, Watson Labs, Watson Labs Teva, and Yaopharma Co Ltd, and is included in one hundred and twenty-six NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Propranolol hydrochloride has sixty-one patent family members in thirty-two countries.
There are twenty-two drug master file entries for propranolol hydrochloride. Thirty-eight suppliers are listed for this compound.
Summary for PROPRANOLOL HYDROCHLORIDE
Recent Clinical Trials for PROPRANOLOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Boston University||Phase 2|
|Central South University||Phase 2|
|McMaster University||Phase 3|
Pharmacology for PROPRANOLOL HYDROCHLORIDE
|Drug Class||beta-Adrenergic Blocker |
|Mechanism of Action||Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for PROPRANOLOL HYDROCHLORIDE
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Ani Pharms Inc||INDERAL LA||propranolol hydrochloride||CAPSULE, EXTENDED RELEASE;ORAL||018553-004||Mar 18, 1987||Start Trial||Start Trial|
|Wyeth Ayerst||INDERAL||propranolol hydrochloride||SUSPENSION;ORAL||019536-001||Dec 12, 1986||Start Trial||Start Trial|
|Ani Pharms Inc||INDERAL LA||propranolol hydrochloride||CAPSULE, EXTENDED RELEASE;ORAL||018553-001||Apr 19, 1983||Start Trial||Start Trial|
|Ani Pharms Inc||INDERAL LA||propranolol hydrochloride||CAPSULE, EXTENDED RELEASE;ORAL||018553-003||Apr 19, 1983||Start Trial||Start Trial|
|Ani Pharms Inc||INDERAL LA||propranolol hydrochloride||CAPSULE, EXTENDED RELEASE;ORAL||018553-002||Apr 19, 1983||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
|Country||Patent Number||Estimated Expiration|
|World Intellectual Property Organization (WIPO)||2009050567||Start Trial|
|World Intellectual Property Organization (WIPO)||03028708||Start Trial|
|Russian Federation||2471500||Start Trial|
|>Country||>Patent Number||>Estimated Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.